HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GPD-1116

phosphodiesterase 4 inhibitor that markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain; structure in first source
Also Known As:
3-benzyl-5-phenyl-1H-pyrazolo(4,3-c)(1,8)naphthyridin-4(5H)-one
Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ishitani, Kouki: 2 articles (01/2016 - 02/2008)
2. Kondo, Miwa: 2 articles (01/2016 - 02/2008)
3. Nose, Takashi: 2 articles (01/2016 - 02/2008)
4. Hamura, Hiroki: 1 article (01/2016)
5. Sekine, Takako: 1 article (01/2016)
6. Shimizu, Masashi: 1 article (01/2016)
7. Yamaguchi, Yusuke: 1 article (01/2016)
8. Akiyoshi, Taeko: 1 article (02/2008)
9. Fukuchi, Yoshinosuke: 1 article (02/2008)
10. Iwase, Akihiko: 1 article (02/2008)

Related Diseases

1. Acute Lung Injury
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Pulmonary Hypertension
4. Asthma (Bronchial Asthma)
5. Emphysema

Related Drugs and Biologics

1. Smoke
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. Phosphodiesterase 4 Inhibitors
4. Phosphoric Diester Hydrolases (Phosphodiesterases)
5. Roflumilast

Related Therapies and Procedures

1. Oral Administration